Inhibitors of protein kinases

US8389521B2 · kind B2 · utility

Assignee

• Ingenium Pharmaceuticals GmbH · DE

Inventors

• Heike Schauerte · Munich, DE
• Hans Allgeier
• Michael A. Pleiss · Sunnyvale, US
• Martin Augustin · Herrsching am Ammersee, DE
• Gisela Peraus · Birkenfeld, DE
• Gabriele Stumm · Unterhaching, DE
• Philipp Wabnitz · Düsseldorf, DE

Key dates

• Filing date: Apr 24, 2008
• Grant date: Mar 5, 2013
• Expiry date: Apr 13, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D403/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).